Cargando…
Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
BACKGROUND: Today's clinical diagnostic tools are insufficient for giving accurate prognosis to breast cancer patients. The aim of our study was to examine the tumor metabolic changes in patients with locally advanced breast cancer caused by neoadjuvant chemotherapy (NAC), relating these change...
Autores principales: | Cao, Maria D, Giskeødegård, Guro F, Bathen, Tone F, Sitter, Beathe, Bofin, Anna, Lønning, Per E, Lundgren, Steinar, Gribbestad, Ingrid S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307437/ https://www.ncbi.nlm.nih.gov/pubmed/22277092 http://dx.doi.org/10.1186/1471-2407-12-39 |
Ejemplares similares
-
Feasibility of MR Metabolomics for Immediate Analysis of Resection Margins during Breast Cancer Surgery
por: Bathen, Tone F., et al.
Publicado: (2013) -
Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014) -
Merging transcriptomics and metabolomics - advances in breast cancer profiling
por: Borgan, Eldrid, et al.
Publicado: (2010) -
DNA methylation changes in response to neoadjuvant chemotherapy are associated with breast cancer survival
por: Pedersen, Christine Aaserød, et al.
Publicado: (2022) -
Serum Levels of Choline-Containing Compounds Are Associated with Aerobic Fitness Level: The HUNT-Study
por: Bye, Anja, et al.
Publicado: (2012)